Institutional Ownership Reata Pharmaceuticals Inc (RETA)
This table provides information about the institutional ownership of Reata Pharmaceuticals Inc (RETA). We have compiled data on the 5 institutions that hold shares in the stock, with a total of 62,710 shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
34,250
shares
|
$0
0.14% of portfolio
|
Q2 2023
Added 91.88%
|
|
|
Eaton Vance Management
Boston, MA |
Nov 14, 2022 Q3 2022 |
15,641
shares
|
$0
0.0% of portfolio
|
Q3 2022
Reduced 0.05%
|
|
|
Stonnington Group, LLC
|
Apr 14, 2023 Q1 2023 |
10,100
shares
|
$0
0.24% of portfolio
|
Q1 2023
New holding
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,646
shares
|
$0
0.0% of portfolio
|
Q2 2023
Reduced 17.42%
|
|
|
Wipfli Financial Advisors Llc,
|
Oct 26, 2022 Q3 2022 |
73
shares
|
$0
0.0% of portfolio
|
Q3 2022
New holding
|